TrialEuropean journal of neurology2021

Botulinum toxin injection into the intrinsic laryngeal muscles to treat spasmodic dysphonia: A multicenter, placebo-controlled, randomized, double-blinded, parallel-group comparison/open-label clinical trial.

Masamitsu Hyodo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.